As previously announced, on December 20, 2016, Nobilis Health
Corp. (NYSE MKT: HLTH) (TSX: NHC) (Nobilis or the Company)
announced today that it has been notified by the Toronto Stock
Exchange (TSX) that the common share purchase warrants issued by
Nobilis on May 13, 2015 (the Warrants), currently listed under
the symbol NHC.WT, are being placed under de-listing review. The
TSX advised Nobilis that the Warrants, as stand-alone securities,
may not meet the minimum price and market value listing
requirements set out in the TSX Company Manual. Unless the
Warrants meet all of the requirements for listing set out in the
TSX Company Manual by April 20, 2017, they will be de-listed from
the TSX 30 days from such date.

Nobilis is evaluating its response, if any, to the de-listing
review in light of its previously stated intent to create a
single trading market for its securities and the Warrants
expiration date of May 13, 2017. The common shares of the Company
remain scheduled for de-listing from the TSX at the close of
markets on December 30, 2016.